This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Ikena Oncology, Inc.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: The Innovations of Thomas A. Wynn
Introduction
Thomas A. Wynn is a prominent inventor based in Lexington, MA, known for his contributions to the field of oncology. With a focus on finding innovative solutions, he has successfully secured a patent that highlights his dedication to advancing medical science.
Latest Patents
Wynn holds one significant patent titled "MEK inhibitors and uses thereof." This patent provides disclosures on MEK inhibitors, their compositions, and various methods for their use, which have important implications for cancer treatment.
Career Highlights
Currently, Thomas A. Wynn works at Ikena Oncology, Inc., a company dedicated to transforming the treatment paradigm for cancer. Through his research and dedication, Wynn has become an integral part of the team, focused on developing novel therapeutic strategies that can improve patient outcomes.
Collaborations
In his professional journey, Wynn collaborates closely with renowned colleagues, including Alfredo C. Castro and Michael J. Burke. This collaborative approach fosters innovation and enhances the development of groundbreaking solutions in oncology.
Conclusion
Thomas A. Wynn exemplifies the spirit of innovation within the field of medicine. His patented work on MEK inhibitors underscores his commitment to making a difference in cancer treatment, and his collaborations with other experts continue to pave the way for future advancements in this critical area of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile